NICE recommends NHS use of innovative treatment for severe blood disorder

red blood cells

Patients suffering from a rare blood disorder may soon have a brand-new treatment after NICE recommended caplacizumab, with plasma exchange and immunosuppression for routine use on the NHS

Please register to continue reading this content

Register for free

Guidelines is completely free for UK-based doctors, nurses, and pharmacists